TABLE 4.
BIS-related measures before/during the COVID-19 pandemic.
|
Pathogen disgust |
Germ aversion |
Infectability |
||||
|
Men |
Women |
Men |
Women |
Men |
Women |
|
| M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | M (SD) | |
| Before pandemic | 3.438 (1.185) | 3.966 (0.992) | 3.577 (1.077) | 3.800 (1.027) | 2.782 (1.115) | 3.189 (1.342) |
| During pandemic | 3.763 (2.201) | 4.109 (1.086) | 4.216 (1.028) | 4.459 (1.073) | 3.079 (0.976) | 3.199 (1.098) |
| ANOVA | F (1, 1597) | Partial η2 | F (1, 1640) | Partial η2 | F (1, 1642) | Partial η2 |
| Time (pre-pandemic/pandemic) | 10.616*** | 0.007 | 111.26*** | 0.064 | 4.939* | 0.003 |
| Gender (men/women) | 36.779*** | 0.023 | 14.301*** | 0.009 | 14.483*** | 0.009 |
| Time × gender | 1.591 | 0.001 | 0.025 | 0.000 | 4.286* | 0.003 |
***p < 0.001. **p < 0.01. *p < 0.05.